About Glaxo Coin Trading Ltd
Company Overview
Glaxo Coin Trading Ltd is a Malta-registered trading company, established on 17 October 2024. The broker operates under the official domain glaxocoinstradingfx.com and lists its registered address as Seabreeze, 10, Giuseppe Cali Street, Ta' xbiex, Malta.
According to FXCanary's records, Glaxo Coin Trading Ltd does not hold any known regulatory licences from a financial authority. This absence of regulation is a significant factor for traders to consider, as it means the broker is not subject to the oversight and client-protection standards imposed by recognised regulators.
Account Types
The broker offers three account tiers, each with a substantial minimum deposit requirement. The Diamond account requires a minimum deposit of $50,000, the Executive account $10,000, and the Deluxe account $5,000. Maximum leverage figures are not specified in the available records.
These high entry thresholds suggest the broker targets high-net-worth individuals rather than retail traders with smaller capital. However, without regulatory oversight and a trading record, the value proposition of these accounts remains unverified.
Instruments and Platforms
At present, FXCanary's data does not indicate which financial instruments Glaxo Coin Trading Ltd offers for trading, nor does it list any trading platforms (such as MetaTrader 4/5 or proprietary software). The broker's website may provide this information, but we have not independently verified it.
Potential traders should exercise caution when a broker is opaque about its trading instruments and technology infrastructure, as these are core components of any credible brokerage service.
Funding and Client Protection
Details on deposit and withdrawal methods are not available in our records. Similarly, since the broker is unregulated, there is no information on client money segregation, negative balance protection, or participation in a compensation scheme.
Regulated brokers in Malta (e.g., those licensed by the MFSA) are required to adhere to strict financial standards. The absence of such regulation at Glaxo Coin Trading Ltd places the onus on the trader to assess and accept the heightened risk.
Target Audience and Suitability
Given the high minimum deposits and lack of regulatory oversight, Glaxo Coin Trading Ltd appears to target a niche of affluent traders who are willing to risk significant capital with an unregulated counterparty. This is an atypical profile for the majority of retail forex and CFD traders.
FXCanary advises that only traders with a very high risk tolerance and a thorough understanding of the specific risks involved should consider engaging with such a broker. For most traders, a regulated alternative would be more appropriate.
Overview compiled by FXCanary from regulatory records and public data. full Glaxo Coin Trading Ltd review